{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:05:43Z","timestamp":1791335143917,"version":"4.3.1"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejpb.2025.114808","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T16:41:59Z","timestamp":1752597719000},"page":"114808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Development, characterization, and optimization of folate-chitosan surface-modified PLGA-decorated mesoporous silica nanoparticles for effective delivery of leflunomide for the management of rheumatoid arthritis"],"prefix":"10.1016","volume":"214","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8162-8515","authenticated-orcid":false,"given":"Walaa A.","family":"El-Dakroury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3942-8034","authenticated-orcid":false,"given":"Fatma Sa\u2019eed","family":"El-Tokhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7679-5968","authenticated-orcid":false,"given":"Gihan F.","family":"Asaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2228-226X","authenticated-orcid":false,"given":"Marwa E.","family":"Shabana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kareem H.","family":"Elsyed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haya A.","family":"Elshafei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa M.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Radwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6260-6209","authenticated-orcid":false,"given":"Abdelrahman R.","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2025.114808_b0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11010-022-04492-3","article-title":"Rheumatoid arthritis: advances in treatment strategies","volume":"478","author":"Prasad","year":"2023","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejpb.2025.114808_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2021.101740","article-title":"Rheumatoid arthritis: Evolving recognition of a common disease","volume":"36","author":"Daikh","year":"2022","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.ejpb.2025.114808_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ocarto.2022.100235","article-title":"Rheumatoid arthritis chondrocytes produce increased levels of pro-inflammatory proteins","volume":"4","author":"\u00d6nnheim","year":"2022","journal-title":"Osteoarthr. Cartil. Open."},{"key":"10.1016\/j.ejpb.2025.114808_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118447","article-title":"Coated nanostructured lipid carriers targeting the joints \u2013 an effective and safe approach for the oral management of rheumatoid arthritis","volume":"567","author":"Zewail","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114808_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123224","article-title":"Chitosan coated clove oil-based nanoemulsion: an attractive option for oral delivery of leflunomide in rheumatoid arthritis","author":"Zewail","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114808_b0030","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2165\/11316650-000000000-00000","article-title":"Benefit-risk assessment of leflunomide: an appraisal of leflunomide in rheumatoid arthritis 10 years after licensing","volume":"32","author":"Alcorn","year":"2009","journal-title":"Drug Saf."},{"key":"10.1016\/j.ejpb.2025.114808_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.121683","article-title":"Folate decorated chitosan-chondroitin sulfate nanoparticles loaded hydrogel for targeting macrophages against rheumatoid arthritis","volume":"327","author":"Siddiqui","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejpb.2025.114808_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/coatings11050548","article-title":"Formulation and optimization of nano lipid based oral delivery systems for arthritis","volume":"11","author":"Gilani","year":"2021","journal-title":"Coatings"},{"key":"10.1016\/j.ejpb.2025.114808_b0045","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3390\/pharmaceutics12050432","article-title":"Mesoporous silica nanoparticles as carriers for therapeutic biomolecules","volume":"12","author":"Castillo","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114808_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2022.214687","article-title":"Recent trends of mesoporous silica-based nanoplatforms for nanodynamic therapies","volume":"469","author":"Xu","year":"2022","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejpb.2025.114808_b0055","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jconrel.2021.10.005","article-title":"Current trends in smart mesoporous silica-based nanovehicles for photoactivated cancer therapy","volume":"339","author":"Wang","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114808_b0060","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jcis.2024.08.172","article-title":"Fe-doped biodegradable dendritic mesoporous silica nanoparticles for starvation therapy and photothermal-enhanced cascade catalysis in tumor therapy","volume":"678","author":"Ye","year":"2025","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejpb.2025.114808_b0065","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1166\/jbn.2015.2072","article-title":"Unique biological degradation behavior of St\u00f6ber mesoporous silica nanoparticles from their interiors to their exteriors","volume":"11","author":"Chen","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ejpb.2025.114808_b0070","article-title":"Development of dual drug loaded PLGA based mesoporous silica nanoparticles and their conjugation with Angiopep-2 to treat glioma","volume":"53","author":"Heggannavar","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2025.114808_b0075","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/adfm.201100403","article-title":"Mesoporous silicon\u2010PLGA composite microspheres for the double controlled release of biomolecules for orthopedic tissue engineering","volume":"22","author":"Fan","year":"2012","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ejpb.2025.114808_b0080","article-title":"Ortho-silicic Acid Prevents Glucocorticoid-Induced Femoral Head Necrosis by Promoting Akt phosphorylation to inhibit endoplasmic reticulum stress-mediated apoptosis and enhance angiogenesis and osteogenesis","volume":"1\u201312","author":"Sun","year":"2024","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.ejpb.2025.114808_b0085","first-page":"366","article-title":"The folate receptor \u03b2 as a macrophage-mediated imaging and therapeutic target in rheumatoid arthritis, Drug Deliv","volume":"9","author":"Chandrupatla","year":"2019","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejpb.2025.114808_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110046","article-title":"Osteoinductive and anti-inflammatory properties of chitosan-based scaffolds for bone regeneration","volume":"105","author":"Fasolino","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ejpb.2025.114808_b0095","doi-asserted-by":"crossref","first-page":"12700","DOI":"10.1016\/j.ceramint.2019.03.125","article-title":"Improvement of hollow mesoporous silica nanoparticles synthesis by hard-templating method via CTAB surfactant","volume":"45","author":"Khoeini","year":"2019","journal-title":"Ceram. Int."},{"key":"10.1016\/j.ejpb.2025.114808_b0100","first-page":"831","article-title":"Multimodal nanoparticles that provide immunomodulation and intracellular drug delivery for infectious diseases, Nanomedicine Nanotechnology","volume":"10","author":"Dube","year":"2014","journal-title":"Biol. Med."},{"key":"10.1016\/j.ejpb.2025.114808_b0105","doi-asserted-by":"crossref","first-page":"18751","DOI":"10.1021\/acsomega.3c00738","article-title":"Synthesis and Evaluation of BSA-loaded PLGA\u2013Chitosan composite nanoparticles for the protein-based drug delivery system","volume":"8","author":"Gaur","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejpb.2025.114808_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2023.111849","article-title":"Folic acid conjugated-chitosan modified nanostructured lipid carriers as promising carriers for delivery of Umbelliprenin to cancer cells: In vivo and in vitro","volume":"186","author":"Sadeghzadeh","year":"2023","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.ejpb.2025.114808_b0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12645-023-00160-3","article-title":"Preparation and characterization of the myricetin-loaded solid lipid nanoparticles decorated with folic acid-bound chitosan and evaluation of its antitumor and anti-angiogenic activities in vitro and in vivo in mice bearing tumor models","volume":"14","author":"Khatamian","year":"2023","journal-title":"Cancer Nanotechnol."},{"key":"10.1016\/j.ejpb.2025.114808_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.106242","article-title":"PEGylated lipid polymeric nanoparticles for management of rheumatoid arthritis","author":"Zewail","year":"2024","journal-title":"J. Drug Deliv Sci. Technol."},{"key":"10.1016\/j.ejpb.2025.114808_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114324","article-title":"Desosomes and desimicelles\u2212 a novel vesicular and micellar system for enhanced oral delivery of poorly soluble drug: Optimization of in vitro characteristics and in vivo performance","volume":"200","author":"Said","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114808_b0130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2016.12.027","article-title":"pH-sensitive polymeric micelles for targeted delivery to inflamed joints","volume":"246","author":"Li","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114808_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260423","article-title":"Effects of different doses of complete Freund\u2019s adjuvant on nociceptive behaviour and inflammatory parameters in polyarthritic rat model mimicking rheumatoid arthritis","volume":"16","author":"Noh","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2025.114808_b0140","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s10787-020-00736-0","article-title":"Anti-inflammatory effect of stevioside abates Freund\u2019s complete adjuvant (FCA)-induced adjuvant arthritis in rats","volume":"28","author":"Alavala","year":"2020","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejpb.2025.114808_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.810052","article-title":"Butin attenuates arthritis in complete freund\u2019s adjuvant-treated arthritic rats: possibly mediated by its antioxidant and anti-inflammatory actions","volume":"13","author":"Alzarea","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114808_b0150","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000362556","article-title":"Synergistic effects of leflunomide and benazepril in streptozotocin-induced diabetic nephropathy","volume":"126","author":"Jin","year":"2014","journal-title":"Nephron. Exp. Nephrol."},{"key":"10.1016\/j.ejpb.2025.114808_b0155","first-page":"539","article-title":"Antioxidant, anti-cancer and anti-arthritic activities of acetogenin-rich extract of avocado pulp","volume":"65","author":"Hassan","year":"2022","journal-title":"Egypt. J. Chem."},{"key":"10.1016\/j.ejpb.2025.114808_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122006","article-title":"Design, characterization and in vivo performance of solid lipid nanoparticles (SLNs)-loaded mucoadhesive buccal tablets for efficient delivery of Lornoxicam in experimental inflammation","volume":"624","author":"Zewail","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114808_b0165","first-page":"161","article-title":"LC-MS-based chemical profiling and in-vivo evaluation of the anti-inflammatory and anti-nociceptive activities of the defatted methanolic extract of Crataegus Sinaica (Rosaceae) fruits","volume":"65","author":"Abdel-Rahman","year":"2022","journal-title":"Egypt. J. Chem."},{"key":"10.1016\/j.ejpb.2025.114808_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-021-03207-3","article-title":"Anti-inflammatory effect of different curcumin preparations on adjuvant-induced arthritis in rats","volume":"21","author":"Rinkunaite","year":"2021","journal-title":"BMC Complement. Med. Ther."},{"issue":"7","key":"10.1016\/j.ejpb.2025.114808_b0175","first-page":"1","article-title":"Amelioration of complete Freund\u2019s adjuvant-induced arthritis by Calotropis procera latex in rats","volume":"71","author":"Patel","year":"2021","journal-title":"Futur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114808_b0180","first-page":"1","article-title":"Analyses of human and rat clinical parameters in rheumatoid arthritis raise the possibility of use of crude Aloe vera gel in disease amelioration","volume":"10","author":"Guha","year":"2014","journal-title":"Immunome Res."},{"key":"10.1016\/j.ejpb.2025.114808_b0185","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/art.30303","article-title":"Imaging studies in Freund\u2019s complete adjuvant model of regional polyarthritis, a model suitable for the study of pain mechanisms, in the rat","volume":"63","author":"Almarestani","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejpb.2025.114808_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030519","article-title":"Poly \u03b5-caprolactone nanoparticles for sustained intra-articular immune modulation in adjuvant-induced arthritis rodent model","volume":"14","author":"Singh","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114808_b0195","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1021\/cm303242h","article-title":"Controlling growth of ultrasmall sub-10 nm fluorescent mesoporous silica nanoparticles","volume":"25","author":"Ma","year":"2013","journal-title":"Chem. Mater."},{"key":"10.1016\/j.ejpb.2025.114808_b0200","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1021\/cm0204371","article-title":"Synthesis of nanoscale mesoporous silica spheres with controlled particle size","volume":"14","author":"Nooney","year":"2002","journal-title":"Chem. Mater."},{"key":"10.1016\/j.ejpb.2025.114808_b0205","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1002\/adfm.201100311","article-title":"Ultrabright fluorescent silica mesoporous silica nanoparticles: control of particle size and dye loading","volume":"21","author":"Cho","year":"2011","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ejpb.2025.114808_b0210","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/pharmaceutics13020184","article-title":"Optimization of mesoporous silica nanoparticles through statistical design of experiment and the application for the anticancer drug","volume":"13","author":"Kim","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114808_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfa.2019.05.053","article-title":"Revising the synthesis of St\u00f6ber silica nanoparticles: a multivariate assessment study on the effects of reaction parameters on the particle size","volume":"577","author":"Fernandes","year":"2019","journal-title":"Colloids Surfaces A Physicochem. Eng. Asp."},{"key":"10.1016\/j.ejpb.2025.114808_b0220","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.colsurfa.2006.08.001","article-title":"An optimized sol\u2013gel synthesis of stable primary equivalent silica particles","volume":"294","author":"Rahman","year":"2007","journal-title":"Colloids Surfaces A Physicochem. Eng. Asp."},{"key":"10.1016\/j.ejpb.2025.114808_b0225","doi-asserted-by":"crossref","first-page":"8478","DOI":"10.1021\/acs.langmuir.5b01637","article-title":"A new insight into growth mechanism and kinetics of mesoporous silica nanoparticles by in situ small angle X-ray scattering","volume":"31","author":"Yi","year":"2015","journal-title":"Langmuir"},{"key":"10.1016\/j.ejpb.2025.114808_b0230","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0021-9797(03)00036-5","article-title":"Synthesis of uniform anatase TiO2 nanoparticles by gel\u2013sol method: 3. Formation process and size control","volume":"259","author":"Sugimoto","year":"2003","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejpb.2025.114808_b0235","doi-asserted-by":"crossref","unstructured":"Z. Yi, C. Feng, L. Kong, D. Cahill, A facile synthesis of mesoporous silica nanoparticle and its morphology manipulation by varying pH value, in: Proc. 2014 Int. Conf. Mater. Sci. ENERGY Eng. (CMSEE 2014), World Scientific, 2015: pp. 413\u2013418.","DOI":"10.1142\/9789814678971_0062"},{"key":"10.1016\/j.ejpb.2025.114808_b0240","doi-asserted-by":"crossref","first-page":"15862","DOI":"10.1039\/D3CP01404E","article-title":"A statistical design approach to the sol\u2013gel synthesis of (amino) organosilane hybrid nanoparticles","volume":"25","author":"Bondarenko","year":"2023","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.ejpb.2025.114808_b0245","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s10934-022-01259-5","article-title":"Synthesis and characterization of amine-functionalized Fe3O4\/Mesoporous Silica Nanoparticles (MSNs) as potential nanocarriers in drug delivery systems","volume":"29","author":"Tabasi","year":"2022","journal-title":"J. Porous Mater."},{"key":"10.1016\/j.ejpb.2025.114808_b0250","doi-asserted-by":"crossref","first-page":"20661","DOI":"10.1038\/s41598-022-25095-4","article-title":"Organically surface engineered mesoporous silica nanoparticles control the release of quercetin by pH stimuli","volume":"12","author":"Saputra","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2025.114808_b0255","doi-asserted-by":"crossref","first-page":"19063","DOI":"10.1039\/D2RA02290G","article-title":"Construction of pH\/reduction dual responsive MSN-HAgel containing HApt for tumor targeting carriers","volume":"12","author":"Liu","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejpb.2025.114808_b0260","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.micromeso.2010.10.035","article-title":"Mesoscale porous silica as drug delivery vehicles: Synthesis, characterization, and pH-sensitive release profiles","volume":"141","author":"DeMuth","year":"2011","journal-title":"Microporous Mesoporous Mater."},{"key":"10.1016\/j.ejpb.2025.114808_b0265","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3390\/pharmaceutics10030118","article-title":"Mesoporous silica nanoparticles: a comprehensive review on synthesis and recent advances","volume":"10","author":"Narayan","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114808_b0270","first-page":"1","article-title":"A kinetic approach to the mechanism of formation of mesoporous silica nanoparticles","author":"Alvarado Meza","year":"2023","journal-title":"J. Sol-Gel Sci. Technol."},{"key":"10.1016\/j.ejpb.2025.114808_b0275","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0167-2991(02)80189-6","article-title":"Influence of pH in mesoporous silica aluminas (MSA) synthesis, in","author":"Rizzo","year":"2002","journal-title":"Stud. Surf. Sci. Catal., Elsevier"},{"key":"10.1016\/j.ejpb.2025.114808_b0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-021-05332-z","article-title":"Hollow mesoporous silica nanoparticles for co-delivery of hydrophobic and hydrophilic molecules: mechanism of drug loading and release","volume":"23","author":"Kabiri","year":"2021","journal-title":"J. Nanoparticle Res."},{"key":"10.1016\/j.ejpb.2025.114808_b0285","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3390\/nano11051293","article-title":"A comprehensive study of drug loading in hollow mesoporous silica nanoparticles: impacting factors and loading efficiency","volume":"11","author":"Guo","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ejpb.2025.114808_b0290","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201701741","article-title":"Encapsulation of hydrophilic and hydrophobic peptides into hollow mesoporous silica nanoparticles for enhancement of antitumor immune response","volume":"13","author":"Xie","year":"2017","journal-title":"Small"},{"key":"10.1016\/j.ejpb.2025.114808_b0295","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.3390\/polym13101539","article-title":"Leflunomide loaded chitosan nanoparticles for the preparation of aliphatic polyester based skin patches","volume":"13","author":"Nanaki","year":"2021","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ejpb.2025.114808_b0300","first-page":"631","article-title":"New folic acid-chitosan derivative based nanoparticles\u2013potential applications in cancer therapy","volume":"51","author":"Alupei","year":"2017","journal-title":"Cellul. Chem. Technol."},{"key":"10.1016\/j.ejpb.2025.114808_b0305","article-title":"Antimicrobial photodynamic inactivation of fungal biofilm using amino functionalized mesoporus silica-rose bengal nanoconjugate against Candida albicans","volume":"1","author":"Paramanantham","year":"2018","journal-title":"Sci. African."},{"key":"10.1016\/j.ejpb.2025.114808_b0310","first-page":"93","article-title":"Functionalized Mesoporous silica nanoparticles as a novel antioxidant delivery system","volume":"12","author":"Iraji","year":"2015","journal-title":"Iran J Chem Eng."},{"key":"10.1016\/j.ejpb.2025.114808_b0315","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bsecv.2019.09.006","article-title":"Synthesis and characterization of amorphous mesoporous silica from palm kernel shell ash, Bolet\u00edn La Soc","volume":"59","author":"Imoisili","year":"2020","journal-title":"Espa\u00f1ola Cer\u00e1mica y Vidr."},{"key":"10.1016\/j.ejpb.2025.114808_b0320","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1080\/13880209.2022.2136208","article-title":"Ameliorative effect of chitosan nanoparticles against carbon tetrachloride-induced nephrotoxicity in Wistar rats","volume":"60","author":"Nomier","year":"2022","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ejpb.2025.114808_b0325","doi-asserted-by":"crossref","first-page":"17401","DOI":"10.1039\/C6DT03323G","article-title":"Folic acid conjugated Fe 3 O 4 magnetic nanoparticles for targeted delivery of doxorubicin","volume":"45","author":"Rana","year":"2016","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.ejpb.2025.114808_b0330","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.saa.2008.12.021","article-title":"Complexation of anthracene with folic acid studied by FTIR and UV spectroscopies","volume":"72","author":"He","year":"2009","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.ejpb.2025.114808_b0335","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.1039\/c0jm04468g","article-title":"Functionalization of upconverted luminescent NaYF4: Yb\/Er nanocrystals by folic acid\u2013chitosan conjugates for targeted lung cancer cell imaging","volume":"21","author":"Chen","year":"2011","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.ejpb.2025.114808_b0340","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s00289-011-0674-x","article-title":"Preparation, characterization, and in vitro release of folic acid-conjugated chitosan nanoparticles loaded with methotrexate for targeted delivery","volume":"68","author":"Ji","year":"2012","journal-title":"Polym. Bull."},{"key":"10.1016\/j.ejpb.2025.114808_b0345","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10068-014-0078-4","article-title":"Preparation, characterization, and in vitro antitumor activity of folate conjugated chitosan coated EGCG nanoparticles","volume":"23","author":"Liang","year":"2014","journal-title":"Food Sci. Biotechnol."},{"key":"10.1016\/j.ejpb.2025.114808_b0350","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.carres.2011.01.027","article-title":"Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells","volume":"346","author":"Li","year":"2011","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ejpb.2025.114808_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2022.112141","article-title":"Synthesis, characterization and in vitro digestion of folate conjugated chitosan-loaded proanthocyanidins nanoparticles","volume":"163","author":"Ding","year":"2023","journal-title":"Food Res. Int."},{"key":"10.1016\/j.ejpb.2025.114808_b0360","first-page":"30","article-title":"Recent biomedical applications and patents on biodegradable polymer-PLGA","volume":"1","author":"Singh","year":"2014","journal-title":"Int. J. Pharmacol. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114808_b0365","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.3109\/03639045.2015.1019355","article-title":"Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity","volume":"41","author":"Singh","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2025.114808_b0370","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4103\/1735-5362.350237","article-title":"Evaluation of PLGA nanoparticles containing outer membrane proteins of Acinetobacter baumannii bacterium in stimulating the immune system in mice","volume":"17","author":"Gholizadeh","year":"2022","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114808_b0375","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1016\/j.apsusc.2006.05.047","article-title":"Surface characteristics of PLA and PLGA films","volume":"253","author":"Thanki Paragkumar","year":"2006","journal-title":"Appl. Surf. Sci."},{"key":"10.1016\/j.ejpb.2025.114808_b0380","article-title":"Fexofenadine-loaded chitosan coated solid lipid nanoparticles (SLNs): a potential oral therapy for ulcerative colitis","volume":"114205","author":"El-Dakroury","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114808_b0385","first-page":"405","article-title":"Amino functionalized chiral mesoporous silica nanoparticles for improved loading and release of poorly water-soluble drug, asian","volume":"14","author":"Wang","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114808_b0390","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1208\/s12249-022-02464-w","article-title":"Quercetin-loaded mesoporous silica nanoparticle\u2013based lyophilized tablets for enhanced physicochemical features and dissolution rate: formulation, optimization, and in vitro evaluation","volume":"24","author":"Elmowafy","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2025.114808_b0395","article-title":"Design, optimization, and in-vivo performance of glipizide-loaded O-carboxymethyl chitosan nanoparticles in insulin resistant\/type 2 diabetic rat model","volume":"79","author":"El-Dakroury","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2025.114808_b0400","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ejps.2016.08.045","article-title":"Stability of folic acid under several parameters","volume":"93","author":"Gazzali","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114808_b0405","first-page":"405","article-title":"Preparation of stable enteric folic acid-loaded microfiber using the electrospinning method","volume":"25","author":"Akhgari","year":"2022","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.ejpb.2025.114808_b0410","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/723158","article-title":"Folic acid\u2010chitosan conjugated nanoparticles for improving tumor\u2010targeted drug delivery","volume":"2013","author":"Song","year":"2013","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.ejpb.2025.114808_b0415","first-page":"221","article-title":"Development and chemical characterization of biodegradable polymeric implants containing sirolimus for the treatment of malignant solid tumors","volume":"74","author":"Campos","year":"2019","journal-title":"Die Pharm. Int. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114808_b0420","doi-asserted-by":"crossref","DOI":"10.1021\/acsabm.4c00019","article-title":"Folate-mediated targeting and controlled release: PLGA-encapsulated mesoporous silica nanoparticles delivering capecitabine to pancreatic tumor","author":"Tripathi","year":"2024","journal-title":"ACS Appl. Biol. Mater."},{"key":"10.1016\/j.ejpb.2025.114808_b0425","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12951-023-01991-3","article-title":"Cracking the intestinal lymphatic system window utilizing oral delivery vehicles for precise therapy","volume":"21","author":"Miao","year":"2023","journal-title":"J. Nanobiotechnology."},{"key":"10.1016\/j.ejpb.2025.114808_b0430","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.addr.2012.10.002","article-title":"The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo","volume":"65","author":"Maeda","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2025.114808_b0435","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jconrel.2007.05.034","article-title":"Effect of acidic pH on PLGA microsphere degradation and release","volume":"122","author":"Zolnik","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114808_b0440","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.carbpol.2017.11.068","article-title":"pH-responsive selenium nanoparticles stabilized by folate-chitosan delivering doxorubicin for overcoming drug-resistant cancer cells","volume":"181","author":"Luesakul","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejpb.2025.114808_b0445","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1039\/C9TB02494H","article-title":"Comparative release kinetics of small drugs (ibuprofen and acetaminophen) from multifunctional mesoporous silica nanoparticles","volume":"8","author":"Lim","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ejpb.2025.114808_b0450","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.colsurfb.2015.09.007","article-title":"Sandwich-like mesoporous silica flakes for anticancer drug transport\u2014Synthesis, characterization and kinetics release study","volume":"136","author":"Mijowska","year":"2015","journal-title":"Colloids Surfaces B Biointerfaces."},{"key":"10.1016\/j.ejpb.2025.114808_b0455","doi-asserted-by":"crossref","first-page":"855","DOI":"10.4155\/tde.15.31","article-title":"Chitosan coatings to control release and target tissues for therapeutic delivery","volume":"6","author":"Jennings","year":"2015","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejpb.2025.114808_b0460","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/jpp\/rgae020","article-title":"Schisandrin B ameliorates adjuvant-induced arthritis in rats via modulation of inflammatory mediators, oxidative stress, and HIF-1\u03b1\/VEGF pathway","volume":"76","author":"Chen","year":"2024","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114808_b0465","first-page":"2487","article-title":"How to model rheumatoid arthritis in animals: from rodents to non-human primates","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejpb.2025.114808_b0470","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1080\/10717544.2020.1818883","article-title":"\u03b2-Sitosterol-loaded solid lipid nanoparticles ameliorate complete Freund\u2019s adjuvant-induced arthritis in rats: involvement of NF-\u043aB and HO-1\/Nrf-2 pathway","volume":"27","author":"Zhang","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2025.114808_b0475","doi-asserted-by":"crossref","first-page":"551","DOI":"10.5650\/jos.ess21413","article-title":"Specneuzhenide ameliorate complete freund adjuvant induced arthritis in rats: involvement of NF-\u03baB and HO-1\/Nrf-2 pathway","volume":"71","author":"Zeng","year":"2022","journal-title":"J. Oleo Sci."},{"key":"10.1016\/j.ejpb.2025.114808_b0480","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3748\/wjg.v9.i2.320","article-title":"Effect of leflunomide on immunological liver injury in mice","volume":"9","author":"Yao","year":"2003","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejpb.2025.114808_b0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107398","article-title":"Leflunomide an immunomodulator with antineoplastic and antiviral potentials but drug-induced liver injury: a comprehensive review","volume":"93","author":"Alamri","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejpb.2025.114808_b0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6882-10-56","article-title":"Evaluation of antiarthritic activity of Strychnos potatorum Linn seeds in Freund\u2019s adjuvant induced arthritic rat model","volume":"10","author":"Ekambaram","year":"2010","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.ejpb.2025.114808_b0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102392","article-title":"An overview of autoantibodies in rheumatoid arthritis","volume":"110","author":"van Delft","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.ejpb.2025.114808_b0500","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis","volume":"7","author":"McInnes","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejpb.2025.114808_b0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2009.09.019","article-title":"Interleukin-6 subfamily cytokines and rheumatoid arthritis: role of antagonists","volume":"10","author":"Jazayeri","year":"2010","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejpb.2025.114808_b0510","article-title":"Anti-inflammatory and antiarthritic activity of anthraquinone derivatives in rodents","volume":"2014","author":"Kshirsagar","year":"2014","journal-title":"Int. J. Inflam."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125001857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125001857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T15:16:39Z","timestamp":1753974999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125001857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":102,"alternative-id":["S0939641125001857"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114808","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development, characterization, and optimization of folate-chitosan surface-modified PLGA-decorated mesoporous silica nanoparticles for effective delivery of leflunomide for the management of rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114808","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114808"}}